Midday Stock Advances and Decliners 11 September 2012

New York, NY -- (SBWIRE) -- 09/11/2012 -- Shares of Cell Therapeutics, Inc (NASDAQ:CTIC) have risen 27% at midday over optimism prior to its presentation at the annual Rodman & Renshaw Global Investment Conference. The company is scheduled to discuss marketing plans for its non-Hodgkin’s lymphoma drug Pixuvri in the European Union. Cell Therapeutics has a market cap of $34.84 million.

Medisafe 1 Technologies Corp (OTC:MFTH) announced yesterday that they anticipate a special one-off dividend of $0.01 for each common share owned, pending a $7 million perpetual license sale of the company’s technology rights. The perpetual license agreement is anticipated to be signed within 30 days pending the results of a due diligence study by the intended buyer. Details of the third party have not been disclosed.

Shares of Transax International Limited (OTC:TNSX) are trading 566.67% higher to $0.01 at midday, after hitting an intra-day high of $0.024 in the early morning session. Transax has a market capitalization of $960,790. There have been 29.60 million shares traded on the session, compared to a 50-day average of 19,154.

Houston American Energy Corporation (AMEX:HUSA) shares are trading 16.36% higher today following on from yesterday’s 12% rise. The company has recently announced the commencement of drilling operations on its Zorro Gris #1 Well, situated in Colombia. The company’s shares recently traded as low as $1.12, dropping from around $7 one year ago.

Shares of Sunesis Pharmaceuticals, Inc (NASDAQ:SNSS) are climbing sharply higher Tuesday, up 37.88% to $3.64 at midday. The company announced that following DSMB recommendations, it will implement a one-time, 225 patient sample size increase to its Phase 3 VALOR trial of vosaroxin in acute myeloid leukemia (AML). They also announced that the DSMB recommendations triggered a $25 million investment into the company. Sunesis has a market capitalization of $171 million.